Diabetic Retinopathy is the leading cause of blindness in people of working age and is the result of the effects of diabetes on the eyes. It damages the blood vessels in the eye such that they either block or leak leading to decreased oxygen and nutrients to the eye nerves. In the most severe cases this can eventually lead to blindness. Diabetic patients require routine eye examinations so related eye problems can be detected and treated as early as possible.

Researchers have found that diabetic patients who are able to maintain appropriate blood sugar levels have fewer eye problems than those with poor control. Diet and exercise play important roles in the overall health of those with diabetes.

Optic nerve disease can lead to partial or complete vision loss when the nerve becomes damaged or deteriorated. This condition can stem from various causes, including glaucoma, inflammatory disorders, or genetic conditions like Leber’s Hereditary Optic Neuropathy.

Unfortunately, traditional treatments offer limited success in restoring lost vision from optic nerve damage. In most cases, once the optic nerve is severely impaired, vision loss becomes permanent. However, regenerative therapies, such as stem cell treatments, are showing potential in repairing nerve damage and supporting nerve function, offering new hope for patients previously thought untreatable.

Retinitis Pigmentosa (RP) is a group of inherited retinal disorders that gradually damage the retina’s light-sensitive cells, leading to progressive vision loss. Although complete blindness is uncommon, many individuals experience a significant decline in night vision and peripheral vision, which can eventually impact daily activities.

RP affects approximately 1 in 3,500 people, and multiple genetic mutations can cause this condition. While there is currently no definitive cure, ongoing research into regenerative therapies, including stem cell treatments, offers hope for slowing or halting the progression of RP.

Stargardt’s Disease is the most common inherited form of juvenile macular degeneration, typically beginning in early childhood or adolescence, often around age 6. This condition leads to the progressive loss of central vision, which is essential for tasks like reading, recognizing faces, and seeing fine details.

In addition to central vision loss, color perception may also be affected. The severity and speed of progression vary from person to person — some individuals retain partial vision for years, while others may experience significant visual impairment early on.

Though there is currently no cure, emerging treatments like stem cell therapy show promise in helping preserve vision and slow disease progression by promoting retinal cell regeneration and reducing inflammation.